Biobankhealing
About:
Biobankhealing develops innovative new drugs based on the intestinal microbial endoplasmic reticulum platform.
Website: http://www.biobankhealing.com/
Top Investors: NH Investment & Securities, ActnerLab, Soosung Asset Management
Description:
Biobankhealing develops innovative new drugs based on the intestinal microbial endoplasmic reticulum platform.
Total Funding Amount:
2.5B KRW
Headquarters Location:
Seongnam, Kyonggi-do, South Korea
Founded Date:
2016-10-01
Contact Email:
bbhsnubh1010(AT)gmail.com
Founders:
Number of Employees:
1-10
Last Funding Date:
2021-07-16
IPO Status:
Private
Industries:
© 2025 bioDAO.ai